GCR News

The Lancet Oncology Commission commentary acknowledges GCR’s contributions to radiotherapy.

MedRad Research highlights the GCR as one of the growing global radiotherapy advocacy groups dedicated to increasing awareness of RT.

Noncoronavirus patients face delayed elective surgeries and medical procedures for other illnesses

Summarising his presentation in the GCR World Cancer Day Webinar, Paul Naine, director of global clinical operations at Elekta, explains why evolving human capabilities alongside technology is the key to improving access to radiation therapy.

The GCR is listed as one of the many resources intended for clinicians, health professionals, patient advocates, and those aiding in the humanitarian effort.

As global access to radiotherapy is often overlooked, the author recommends device manufacturers can help advocate for radiotherapy at a political, policy, industry, scientific, patient and national cancer plan level by becoming members of organisations like the Global Coalition for Radiotherapy.